{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:26:43Z","timestamp":1762918003344},"reference-count":31,"publisher":"Japanese Society of Internal Medicine","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.2169\/internalmedicine.2000-18","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T22:04:28Z","timestamp":1553724268000},"page":"1953-1960","source":"Crossref","is-referenced-by-count":5,"title":["IL-6-producing Renal Cell Carcinoma Causing Renal and Endocrine Paraneoplastic Syndromes"],"prefix":"10.2169","volume":"58","author":[{"given":"Akira","family":"Okada","sequence":"first","affiliation":[{"name":"Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Japan"},{"name":"Department of Nephrology, Tokyo Teishin Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Higashihara","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Japan"},{"name":"Department of Nephrology, Tokyo Teishin Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiko","family":"Kusano","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tokyo Teishin Hospital, Japan"},{"name":"Department of Internal Medicine, Kasuganokai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Takemura","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Japan"},{"name":"Department of Nephrology, Tokyo Teishin Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanako","family":"Saigusa","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Japan"},{"name":"Department of Nephrology, Tokyo Teishin Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayako","family":"Maruno","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tokyo Teishin Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mimiko","family":"Matsumura","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tokyo Teishin Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Tokyo Teishin Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Analytic Human Pathology, Graduate School of Medicine, Nippon Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Takano","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tokyo Teishin Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Singh P, Rifkin DE, Blantz RC. Chronic kidney disease: an inherent risk factor for acute kidney injury? Clin J Am Soc Nephrol 5: 1690-1695, 2010.","DOI":"10.2215\/CJN.00830110"},{"key":"2","unstructured":"2. Christiansen CF, Johansen MB, Langeberg WJ, Fryzek JP, Sorensen HT. Incidence of acute kidney injury in cancer patients: a Danish population-based cohort study. Eur J Intern Med 22: 399-406, 2011."},{"key":"3","unstructured":"3. Umanath K, Lewis JB. Update on diabetic nephropathy: core curriculum 2018. Am J Kidney Dis 71: 884-895, 2018."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Orgel E, Mittelman SD. The links between insulin resistance, diabetes, and cancer. Curr Diab Rep 13: 213-222, 2013.","DOI":"10.1007\/s11892-012-0356-6"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Spranger J, Kroke A, Mohlig M, et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52: 812-817, 2003.","DOI":"10.2337\/diabetes.52.3.812"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kaminska K, Czarnecka AM, Escudier B, Lian F, Szczylik C. Interleukin-6 as an emerging regulator of renal cell cancer. Urol Oncol 33: 476-485, 2015.","DOI":"10.1016\/j.urolonc.2015.07.010"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. West HJ, Jin JO. JAMA oncology patient page. Performance status in patients with cancer. JAMA Oncol 1: 998, 2015.","DOI":"10.1001\/jamaoncol.2015.3113"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Yamashita T, Noiri E, Hamasaki Y, et al. Erythropoietin concentration in acute kidney injury is associated with insulin-like growth factor-binding protein-1. Nephrology (Carlton) 21: 693-699, 2016.","DOI":"10.1111\/nep.12656"},{"key":"9","unstructured":"9. Pelosof LC, Gerber DE. Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin Proc 85: 838-854, 2010."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Davison AM. Renal diseases associated with malignancies. Nephrol Dial Transplant 16: 13-14, 2001.","DOI":"10.1093\/ndt\/16.suppl_6.13"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kobayashi S, Maesato K, Moriya H, Ohtake T, Ikeda T. Insulin resistance in patients with chronic kidney disease. Am J Kidney Dis 45: 275-280, 2005.","DOI":"10.1053\/j.ajkd.2004.09.034"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Mak RH, DeFronzo RA. Glucose and insulin metabolism in uremia. Nephron 61: 377-382, 1992.","DOI":"10.1159\/000186953"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Hemminki K, Li X, Sundquist J, Sundquist K. Risk of cancer following hospitalization for type 2 diabetes. Oncologist 15: 548-555, 2010.","DOI":"10.1634\/theoncologist.2009-0300"},{"key":"14","unstructured":"14. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 166: 1871-1877, 2006."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Rao Kondapally Seshasai S, Kaptoge S, Thompson A, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364: 829-841, 2011.","DOI":"10.1056\/NEJMoa1008862"},{"key":"16","unstructured":"16. Chen L, Li H, Gu L, et al. The impact of diabetes mellitus on renal cell carcinoma prognosis: a meta-analysis of cohort studies. Medicine (Baltimore) 94: e1055, 2015."},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Lowe G, Woodward M, Hillis G, et al. Circulating inflammatory markers and the risk of vascular complications and mortality in people with type 2 diabetes and cardiovascular disease or risk factors: the ADVANCE study. Diabetes 63: 1115-1123, 2014.","DOI":"10.2337\/db12-1625"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Wong G, Hayen A, Chapman JR, et al. Association of CKD and cancer risk in older people. J Am Soc Nephrol 20: 1341-1350, 2009.","DOI":"10.1681\/ASN.2008090998"},{"key":"19","unstructured":"19. Chen DP, Davis BR, Simpson LM, et al. Association between chronic kidney disease and cancer mortality: a report from the ALLHAT. Clin Nephrol 87: 11-20, 2017."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Rosner MH, Perazella MA. Acute kidney injury in patients with cancer. New Engl J Med 376: 1770-1781, 2017.","DOI":"10.1056\/NEJMra1613984"},{"key":"21","unstructured":"21. Salahudeen AK, Bonventre JV. Onconephrology: the latest frontier in the war against kidney disease. J Am Soc Nephrol 24: 26-30, 2013."},{"key":"22","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.2337\/dc06-0677","volume":"29","author":"S Mizuhashi","year":"2006","unstructured":"22. Mizuhashi S, Nakamura K, Mori Y, Noda M, Nakanishi K. Insulin allergy and immunologic insulin resistance caused by interleukin-6 in a patient with lung cancer. Diabetes Care 29: 1711-1712, 2006.","journal-title":"Diabetes Care","ISSN":"http:\/\/id.crossref.org\/issn\/0149-5992","issn-type":"print"},{"key":"23","unstructured":"23. Yoshiuchi I, Itoh N, Nakano M, Tatsumi C, Yokoyama K, Matsuyama T. Case report of Klinefelter's syndrome with severe diabetes, dyslipidemia, and stroke: the effect of pioglitazone and other anti-inflammatory agents on interleukin-6 and -8, tumor necrosis factor-alpha, and C-reactive protein. Diabetes Care 29: 1981, 2006."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Jones SA, Fraser DJ, Fielding CA, Jones GW. Interleukin-6 in renal disease and therapy. Nephrol Dial Transplant 30: 564-574, 2015.","DOI":"10.1093\/ndt\/gfu233"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Liu F, Guo J, Zhang Q, et al. The expression of tristetraprolin and its relationship with urinary proteins in patients with diabetic nephropathy. PloS One 10: e0141471, 2015.","DOI":"10.1371\/journal.pone.0141471"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Huang Z, Wen Q, Zhou SF, Yu XQ. Differential chemokine expression in tubular cells in response to urinary proteins from patients with nephrotic syndrome. Cytokine 42: 222-233, 2008.","DOI":"10.1016\/j.cyto.2008.02.005"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Yamaguchi J, Tanaka T, Nangaku M. Recent advances in understanding of chronic kidney disease. F1000Res 4, 2015.","DOI":"10.12688\/f1000research.6970.1"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Okada A, Nangaku M, Jao TM, et al. D-serine, a novel uremic toxin, induces senescence in human renal tubular cells via GCN2 activation. Sci Rep 7: 11168, 2017.","DOI":"10.1038\/s41598-017-11049-8"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Hsieh JJ, Purdue MP, Signoretti S, et al. Renal cell carcinoma. Nat Rev Dis Primers 3: 17009, 2017.","DOI":"10.1038\/nrdp.2017.10"},{"key":"30","unstructured":"30. Palapattu GS, Kristo B, Rajfer J. Paraneoplastic syndromes in urologic malignancy: the many faces of renal cell carcinoma. Rev Urol 4: 163-170, 2002."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Yaghoubi F, Yarmohammadi M, Vasei M. Paraneoplastic proteinuria in papillary renal cell carcinoma; a case report. J Renal Inj Prev 5: 207-209, 2016.","DOI":"10.15171\/jrip.2016.44"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/13\/58_2000-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T03:43:06Z","timestamp":1562384586000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/13\/58_2000-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":31,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2000-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,1]]}}}